JP6724186B2 - Display device, server, display method and program for displaying clinical test value - Google Patents

Description

The present invention relates to a display device, a server, a display method and a program for displaying a clinical test value.

The development of information processing technology has spread widely to medical institutions such as pharmacies that dispense and provide medicines, and enhance convenience. For example, in medical institutions, computers such as a receipt computer that supports the creation of a medical bill (medical remuneration statement) have been known in the past, and it is possible to create a medical receipt without requiring specialized knowledge or complicated calculations. ing. In recent years, a system that electronically manages patient information such as medication history has become widespread.

Note that, in the past, since the computer and the system for managing the medication history were hardware independent computers, for example, in Patent Document 1, a pharmacy computer having a receipt computer function and a medication history management function has both functions. A pharmacy computer that effectively cooperates is disclosed.

JP, 2011-118535, A

By the way, a prescription audit is conducted to confirm whether or not there is a suspicion that the drug should be delivered as it is, based on the prescription information, patient information, drug history, etc., when dispensing the drug to the patient. In such a prescription inspection, there are cases in which reference is made to a clinical test value that can grasp the condition of the patient's injury or illness and the influence of the drug taken. However, there are many clinical test values, and even if the many clinical test values that have been input are displayed in a dumb manner, it is not possible to efficiently grasp the information regarding the target illness/drug. As a result, even if information such as clinical test values is displayed for prescription inspection, it is not possible to efficiently search for information on necessary clinical test values, making it impossible to perform appropriate prescription inspection promptly.

The present invention has been made in view of such a situation, and provides a display device and a program for displaying a clinical test value capable of efficiently grasping information necessary for prescription inspection for a prescription prescribed to a patient. With the goal.

(1) Grouping means for accepting a drug and a clinical test value described in a prescription and grouping the clinical test value based on the relationship between the drug and the clinical test value, and grouped clinical test values for each group A display device for displaying a clinical test value, comprising:

(2) In the grouping, the display device for displaying the clinical test value according to (1), in which one clinical test value may be classified into different groups for each drug.

(3) The display device for displaying the clinical test value according to (1) or (2), wherein the grouping is performed for each drug effect and each drug side effect.

(4) The grouping is the display device for displaying the clinical test value according to (3), which may be classified into the side effect part of the drug when the value of the clinical test value is a predetermined value.

(5) The display means displays a clinical test value having the relationship with the drug and a clinical test value having no relationship with the drug in response to the selection of the drug being accepted. A display device for displaying the clinical test value according to any one of (1) to (4).

(6) The display device for displaying the clinical test value according to any one of (1) to (5), wherein the display unit distinguishes and displays the clinical test value at a place where the clinical test value is acquired.

(7) A grouping step of accepting the drug and the clinical test value described in the prescription and grouping the clinical test value based on the relationship between the drug and the clinical test value, and the grouped clinical test value for each group A program that causes a computer to execute a display step that is displayed on the display unit in a distinguishable manner.

It should be noted that the selection of the drug column, the prescription audit-related information column and the intersection column may be performed by accepting selection of any one of the columns and displaying specific information. Only the drug column, the prescription audit-related information are selected. Selection, crossing column only, drug column and prescription audit related information column, drug column and prescription audit related information column, prescription audit related information column and crossing column, or drug column and prescription audit related Specific information may be displayed by selecting the information column and the intersection column.

According to the present invention, it is possible to efficiently grasp the information necessary for prescription inspection of a prescription prescribed to a patient.

It is a figure which shows the structure of the display system which displays a clinical test value. It is a figure which shows the outline of a drug provision business. It is a block diagram which shows the function structure of the display apparatus which displays a clinical test value. It is a figure which shows patient DB of a memory|storage part. It is a figure which shows the clinical test value DB of a memory|storage part. It is a figure which shows the attached document DB of a memory|storage part. It is a figure which shows an example of the display screen displayed on the display device which displays a laboratory test value. It is a figure which shows an example of the display screen displayed on the display device which displays a laboratory test value. It is a flowchart which shows the flow of a process of the display system which displays a clinical test value. It is a block diagram which shows the function structure of the display apparatus which displays a clinical test value. It is a figure which shows patient DB of a memory|storage part. It is a figure which shows an example of the display screen displayed on the display device which displays a laboratory test value.

An embodiment of the present invention will be described below with reference to the drawings.

[First Embodiment]
[Configuration of display system 100 for displaying clinical laboratory values]
Referring to FIG. 1, a display system 100 for displaying a clinical test value according to the present invention includes a display device 2a... And a display 3 for notifying the progress status of the drug provision work.

The display devices 2a... 2n for displaying the clinical test values are terminal devices used by persons in charge of each work constituting the drug providing work.
Here, referring to FIG. 2(1), in the drug provision business, after accepting a prescription from a patient at a counter, the drug is dispensed according to the prescription, and when the final inspection finds that the dispensing is appropriate, It is composed of a series of flows such as providing the drug to the patient at the counter. As an example, such a drug providing business includes each work shown in FIG. 2(2), that is, "reception", "drug history confirmation", "prescription audit", "collecting patient information", "dispensing design", "explanation regarding medication", "dispensing decision". “Dispensing” “final audit” “drug delivery accounting”. Some of these tasks can proceed independently of each other, and in the present embodiment, the tasks are divided by a plurality of persons in charge. For example, in each of the operations that make up the drug provision business, the pharmacist A takes charge of “reception”, “patient information collection”, “dispensing”, and “drug delivery accounting”, and “drug history confirmation”, “prescription audit”, “dispensing design”, “dispensing design” It is assumed that the pharmacist B is in charge of “explanation regarding taking medication” and “dispensing decision”, and the pharmacist C is in charge of “final audit”.
In this embodiment as described above, for example, the display device 2a that displays the clinical test value is used by the pharmacist A, and the display device 2b that displays the clinical test value is used by the pharmacist B, and the display device that displays the clinical test value. 2c will be used by the pharmacist C. Of course, the display devices 2a... 2n for displaying the clinical test values are not limited to being used by one person in charge, but may be shared by a plurality of persons in charge. Note that the configurations of the display devices 2a... 2n that display the clinical test values are basically the same, and hence they may be simply referred to as "display devices 2 that display the clinical test values" hereinafter.

The administrator device 1 is a terminal device that is used by an administrator who manages each person in charge, and has administrator authority such as expansion, modification, and restriction of the function of the display device 2 that displays a clinical test value. It is a general-purpose personal computer that includes a control unit for performing the above and a storage unit for storing various information, an input unit realized by a keyboard, a touch panel, and the like, and a display unit by a display.

The display device 2 for displaying the clinical test value is intended to support the work of the pharmacy in a multi-faceted manner, and is realized by a general-purpose personal computer like the administrator device 1. Various programs are installed in the display device 2 that displays such clinical laboratory values, and the control unit operates according to these programs, so that the prescription audit is performed in addition to the receipt computer function, the drug history management function, and the work sharing function. In ", the display function of the clinical test value is exerted. The clinical test value is referred to when grasping the state of the patient's injury or illness, the degree of influence of the drug, and is a value obtained by qualitatively or quantitatively measuring the components or cells contained in the patient. , Refer to the pharmacy to understand in the "prescription audit" whether the effect of the drug is sufficient or whether side effects of the drug have occurred.
The administrator device 1 and the display device 2 for displaying the clinical test value are connected by a predetermined network line, and cooperate with each other to support a drug providing operation for a patient.

The display 3 is arranged so as to face the side of the patient who has visited the pharmacy, and displays the progress status indicating the progress of the drug providing work for the patient. The display 3 is communicatively connected to the administrator device 1 and/or the display device 2 for displaying the clinical test value, and according to the instruction from the administrator device 1 and/or the display device 2 for displaying the clinical test value, the progress status Is displayed.

[Functional configuration of the display device 2 for displaying the clinical test value]
Next, the configuration of the display device 2 that displays the clinical test value will be described with reference to FIG. The display device 2 that displays the clinical test value includes, in the control unit 21, a reception unit 211, an extraction unit 212, a grouping unit 213, and a display unit 214, and in a region of the storage unit 22, a patient DB 221 and , And a clinical test value DB 222 and an attached document DB 223.

The reception unit 211 receives the content of the prescription and the clinical test value of the patient at the specific visit of the patient, and stores the prescription content and the clinical test value in the patient DB 221 in association with the patient ID.
Here, the prescription content is information about the content described in the prescription and information that accompanies reception of the prescription, for example, patient specific information such as a patient name, a prescription drug indicating a prescribed drug. And the date of receipt indicating the date when the prescription was received by the pharmacy, the initial administration indicating whether the drug described in the prescription was first prescribed to the patient, and the like.
Further, the clinical test value is, for example, a component/cell possessed by the patient by performing a biopsy on the patient's condition such as blood pressure and pulse, and analyzing a sample collected from the patient such as blood glucose level, red blood cell count, urinary protein and γ-GTP. It is stored including the sample test of.
The prescription content and clinical test values received by the reception means 211 are, as described later, when the extraction means 212 extracts past prescription content and clinical test values of the patient, and the grouping means 213 groups the clinical test values. It is used when doing.

The extraction means 212 extracts from the patient DB the past prescription content and the type and value of the clinical test value associated with the patient ID of the patient who received the prescription. In addition, the extraction unit 212 extracts the relationship between the drug included in the received prescription content and the clinical test value from the clinical test value DB 222 based on the received prescription content and the type and value of the clinical test value.

The patient DB 221 will be described with reference to FIG. The patient DB 221 is a DB that stores the prescription content and the clinical test value received at the pharmacy, and stores the prescription content and the clinical test value received by the receiving unit 211 in association with the patient ID. The patient DB 221 stores a “patient ID” in which information for identifying a patient is stored, a “patient name” in which the name of the patient is stored, a “reception date” in which the date on which the prescription is received, and a prescription that is the content of the received prescription. Configured to have a “drug” in which the accepted drug is stored, a “clinical test value item” in which the type of accepted clinical test value is stored, and a “clinical test value” in which the value of the accepted clinical test value is stored Has been done. As the value of “clinical test value”, in addition to a quantitative value such as a specific number, a qualitative value indicating the presence or absence of the clinical test value is stored. For example, the clinical test value of systolic blood pressure stores a quantitative value that is a specific number of 95 mgHG, and the clinical test value of urinary protein is detected as being present or absent. A qualitative value indicating that is stored. In addition to such information, the patient DB 221 may be configured to include information regarding other personal information of the patient, drug information, and clinical test value information.

Further, the clinical test value DB 222 will be described with reference to FIG. The clinical test value DB 222 is a DB having a relationship table that stores relationships between drugs and types and values of clinical test values, and a normal value table that stores normal values of clinical test values. The relationship table includes “drug” that is information on a drug, “clinical test value item” that stores the type of clinical test value, “clinical test value” that stores the value of the clinical test value, and the drug and the clinical test value. The “relationship”, which is the relationship between the type and the value, is stored. The normal value table stores clinical test values and their normal values.
In addition to such information, the clinical test value DB 222 may be configured to include other information regarding the relationship between the drug and the clinical test value. The normal value table may be configured to have different normal values depending on sex, age, and the like.
Here, the “relationship” is specifically information indicating how the clinical test value is related to the drug. For example, the clinical test value called systolic blood pressure is “ Information that the relationship is “effect of drug” is stored. Further, for example, the information that the clinical test value of γ-GTP is related to “drug side effect” is stored for the drug of antihypertensive drug A. Further, such a relationship is not limited to the effect and side effect of the drug, and may have three or more relationships. For example, for the drug of antihypertensive drug A, the clinical test value of pulse is “effect of drug (not applicable)”. A relationship such as “” may be provided. The term “off-label” as used herein means to use for the purpose of symptoms not included in the approval content of the drug.
Further, the “relationship” may be configured such that the relationship changes depending on the value even if the same drug and the type of clinical test value are used. For example, while the information that the clinical test value of systolic blood pressure for the drug of antihypertensive drug A is related to “effect of drug” is stored, if the value of systolic blood pressure is “100 mgHG or less”, “drug The information that the relationship is “side effect of” is also stored. In this case, for the antihypertensive agent A, if the systolic blood pressure exceeds 100 mgHG, the systolic blood pressure is classified only into the "drug effect". Classified as "drug side effects".

The attached document DB 223 will be described with reference to FIG. In the attached document DB 223, data of attached documents of medicines is stored in association with medicines for each item. The package insert is a product information description document for doctors and medical institutions concerned, which describes the drug name, precautions for use, item specifications, and other important items regarding the drug. In the package insert DB 223, in addition to the drug name, information such as indications of indications and dosages, precautions for use, side effects, etc. are stored in association with the items of the package insert. Further, although not particularly shown, in addition to the information described in the package insert, items other than the package insert such as long-term administration check drug and high-risk drug may be provided.

The grouping unit 213 groups the clinical test values for each drug based on the relationship between the drug and the clinical test value extracted by the extracting unit 212.
Here, the reason why the grouping unit 213 groups the clinical test values for each drug will be described. When prescribing to a patient, the condition of the patient's injury or illness is checked in order to perform a prescription audit to confirm whether there is a suspicion that the drug should be delivered as it is, based on the prescription information, patient information, drug history, etc. -References may be made to clinical laboratory values that can understand the effects of the drug you are taking. However, there are many clinical laboratory values, and even if all the clinical laboratory values for which information was obtained are displayed during the prescription audit, clinical laboratory values that are not affected by the prescribed drug are included. There is. As described above, if the clinical test value that is not affected by taking the drug is displayed, there is a possibility that the clinical test value that should be grasped at the time of prescription inspection may not be grasped or that it may take time to grasp. In addition, even if the clinical laboratory value related to the drug administration affects the clinical laboratory value related to the effect of the drug and the clinical laboratory value related to the side effect of the drug, the pharmacist may determine the clinical laboratory value during the prescription audit. I can't grasp it intuitively.
Therefore, the display device 2 that displays the clinical test values displays the clinical test values that the drug influences, and displays the clinical test values by grouping each drug based on the relationship between the drug and the clinical test value. To do.

Specifically, a process in which the grouping unit 213 groups clinical test values for each drug based on the relationship between the drug and the clinical test value will be described as an example. In the present embodiment, for example, the grouping unit 213 determines the maximum blood pressure, the pulse, the γ-GTP and the blood glucose level, which are the clinical test values of the extracted patient instep, in the drug A, the maximum blood pressure, the minimum blood pressure and the pulse are "Effect of". Moreover, since the maximum blood pressure of the patient A is 90 mgHG, in the drug A, the maximum blood pressure and γ-GTP are grouped as “drug side effects”.
Here, the systolic blood pressure, the diastolic blood pressure, and the pulse are regarded as the same group as the “drug effect”, but the relationship between the drug A and the pulse is “drug effect (non-adaptation)”, and therefore Also, the lowest blood pressure may be defined as the “drug effect”, and the pulse may be defined as a “drug effect (out of indication)”, which is different from the “drug effect”.

The display unit 214 groups the clinical test values based on the prescription content and the clinical test value received by the receiving unit 211 and the clinical test value and the relationship extracted by the extracting unit 212, and the respective clinical test values are the drug and the clinical value. Data of a display screen configured to be distinguishable for each relationship with the inspection value is generated and displayed on the display unit 24. Further, the display unit 214 displays the medication period of the drug based on the received prescription content and the past prescription content extracted by the extraction unit 212. In addition, the display means 214, in response to accepting the selection of the displayed drug from the input unit 23, limits the clinical test value for the drug, groups the clinical test values, and sets each clinical test value as a drug. Data of a display screen configured to be distinguishable for each relationship with the clinical test value is generated and displayed on the display unit 24.

Here, display screen data displayed on the display unit 24 by the display unit 214 will be described with reference to FIG. 7. FIG. 7 is a diagram showing that the display screen data generated by the display means 214 is displayed on the display unit 24. The displayed screen shows that the pharmacist “Azuma Taro” audits the prescription of the prescription for the patient “A”. 8 is an example of a display screen displayed when the pharmacist “Taro Higashi” selects “drug A” when performing. The pharmacist refers to this screen, performs a prescription audit, and confirms the prescription content based on the description items of the prescription, patient information/medical history, and clinical test values.

The display area V1 is a screen showing the medication period of the prescribed drug. In the display area V1, the date is displayed on the horizontal axis, and the content of the prescription accepted by the accepting unit 211 and the medicine prescribed in the past are displayed on the vertical axis. Then, a bar indicating the period during which the drug is prescribed is displayed in the center. For example, like B1, it indicates that the drug B is prescribed for 7 days from May 1st. Also, if the medication period of the prescribed prescription and the medication period of the prescription before and after it overlap, the bars will be shifted up and down so that the bars do not overlap and the medication period is A bar indicating that is displayed below the overlapping period. For example, like B2, the bar showing drug A for 21 days prescribed on April 16 shifts up, and the bar showing drug A for 30 days prescribed on May 1 moves down. As a result, the bars indicating the overlap are displayed during the period from May 1st to May 6th.
The medicines displayed in the display area V1 are adapted to display clinical test values relating to the selected medicines in a display area V2, which will be described later, in response to the selection being accepted.

In the display areas V2, V3 and V4, the clinical test values of the prescribed drug are displayed in a distinguishable manner. In V2, V3, and V4 of FIG. 7, the selection of the drug A is accepted, and the clinical test values related to the drug A are displayed in a distinguishable manner for each relationship.
In the display area V2, the clinical test value whose relationship with the drug A is “effect of drug” is displayed. For example, in the display area V2, the systolic blood pressure, the diastolic blood pressure, and the pulse rate whose relationship with the drug A is “effect of drug” are displayed as the same group. Further, in the display area V3, a clinical test value whose relationship with the drug A is “side effect of drug” is displayed. For example, systolic blood pressure, γ-GTP, and urinary protein having a relationship of “drug side effect” with drug A are displayed as the same group. The systolic blood pressure displayed in "drug side effects" is displayed in "drug side effects" because the value on May 1 is 100 or less, but when the systolic blood pressure value is 100 or less Without it, the systolic blood pressure is not displayed in the “drug side effects”.

The display area V4 receives the selection of the drug A and displays the clinical test value that is not related to the drug A. For example, fasting blood glucose and HbA1C, which are not affected by the drug A, are displayed as the same group.

In the display areas V2, V3 and V4, graphs showing changes in the respective clinical test values are displayed. The horizontal axis of the graph shows the month and day, and the vertical axis of the graph shows the value of the clinical test value. Also, in the center of the graph, the normal value range showing the normal value of the clinical test value is shown, and the quantitative clinical test value is displayed as the diagram of the clinical test value. Has become. In addition, the qualitative clinical test value is displayed as +- so that the presence or absence thereof can be understood.
Here, the month and day on the horizontal axis can be changed by pressing the scale up or down button, and can be changed from the daily unit to the weekly unit or the monthly unit. Further, the clinical laboratory value on the vertical axis is obtained by extracting the normal laboratory test value displayed from the clinical laboratory value DB 222, and setting the scale unit on the vertical axis so that the range of the normal laboratory test values is the same. Is adjusted and displayed. For example, the systolic blood pressure, the diastolic blood pressure, and the pulse displayed in V3 are 100-129, 60-79, and 50-90, respectively, and the normal value ranges are displayed vertically so that the normal value ranges in the graph are displayed. The values of the axis scale (the lower limit of the scale, the interval between the scales and the upper limit of the scale) are adjusted to be different for each clinical test value.

Thus, the necessity of the vertical axis so that the normal value range displays are the same will be described with reference to the simplified FIG.
In V5 of FIG. 8, the systolic blood pressure and the diastolic blood pressure are displayed, but the scales of the respective clinical test values are displayed to be the same, and the normal value range display is displayed differently. However, when displayed in this way, there is a problem that it is difficult to intuitively understand which clinical test value the normal range corresponds to, and such a problem arises. The more the number increases, the more difficult it is to understand intuitively.
Therefore, in the display device 2 that displays the clinical test value, the scale value is adjusted so that the normal value range is the same range in different types of clinical test values.
The display of FIG. 7 and the display of FIG. 8 may be switched to each other upon receiving the user's selection.

[Operation of the display device 2 for displaying the clinical test value]
Next, with reference to FIG. 8, the operation of the display device 2 that displays the clinical test value will be described.
First, the reception unit 211 receives the prescription content and/or the clinical test value (step S1). Then, the reception means 211 links|relates the received prescription content and/or the clinical test value with patient ID, and memorize|stores in patient DB221 (step S2). After that, the extraction means 212 extracts information about past prescription contents and clinical test values necessary for generating the display image data, and information on the relationship between the drug and the clinical test values (step S3). After that, the grouping unit 213 groups the clinical test values for each drug based on the relationship between the drug and the clinical test value extracted by the extracting unit 212 (step S4). Thereafter, the display unit 214 groups the clinical test values into groups based on the prescription contents and the clinical test values received by the receiving unit 211, and the clinical test values and the relationships extracted by the extracting unit 212, and the clinical test values are the drugs. The data of the display screen configured so as to be distinguishable for each relationship between the test value and the clinical test value is generated (step S5). After that, the display unit 214 outputs the generated display screen data to the display unit 24 (step S6).

After that, the reception unit 211 receives the selection of the medicine (step S7). Then, the display means 214 produces|generates the data of the display screen limited to the clinical test value regarding the selected chemical|medical agent, when the reception means 211 received the selection of a chemical|medical agent (step S8). After that, the display unit 214 outputs the generated display screen data to the display unit 24 (step S9).

As described above, in the present embodiment, the clinical laboratory values that are not influenced by the prescribed drug are not displayed, but only the clinical laboratory values related to the prescribed drug are displayed. It is possible to properly grasp the efficacy and side effects of the drug, and to efficiently grasp the information necessary for prescription audit of the prescription prescribed to the patient.

In addition, in the present embodiment, the clinical test values that are not affected by the prescribed drug are not displayed, but only the clinical test values related to the prescribed drug are displayed. Efficacy and side effects can be properly grasped, and information necessary for prescription audit for prescription prescribed to the patient can be grasped efficiently.

Further, in the present embodiment, among the prescribed drugs, the clinical test values that are not affected by the drug selected by the pharmacist are not displayed, but only the clinical test values related to the drug selected by the pharmacist are displayed. Therefore, the pharmacist can appropriately understand which of the prescribed drugs influences the clinical test value and causes the efficacy and side effects, and can perform a prescription audit for the prescription prescribed to the patient. It is possible to efficiently grasp the necessary information.

In addition, in the present embodiment, the clinical test values that are not affected by the prescribed drug are not displayed, and only the clinical test values related to the prescribed drug are displayed. Differently displayed, the pharmacist can intuitively understand the meaning of the displayed clinical test value among the prescribed drugs, and efficiently obtain the information necessary for prescription audit for the prescription prescribed to the patient. Can be understood.

[Second Embodiment]
In the first embodiment, the display device 2 includes a reception unit 211, an extraction unit 212, a grouping unit 213, and a display unit 214 in the control unit 21, and a patient DB 221 in one area of the storage unit 22. , The clinical laboratory value DB 222 and the package insert DB 223.
On the other hand, in the present embodiment, as shown in FIG. 10, the control unit 21 includes a reception unit 211a, an extraction unit 212, a grouping unit 213, a display unit 214a, and a display switching reception unit 215. An area of the storage unit 22 includes a patient DB 221a, a clinical test value DB 222, and an attached document DB 223.
The functional configuration of this embodiment will be described below. The description of the same functions as those in the first embodiment will be omitted.

The reception unit 211a receives the content of the prescription at a specific visit of the patient, the clinical test value of the patient, and the acquisition location of the clinical test value, and associates the prescription content with the patient ID, the clinical test value, and the acquisition location of the clinical test value. Is stored in the patient DB 221a.
The reception unit 211a determines the acquisition location of the clinical test value such as whether the subject who acquired the clinical test value is a medical institution or a patient, or what type of medical institution is if the subject who acquired the clinical test value is a medical institution. Accept in a distinguishable manner.

The patient DB 221a will be described with reference to FIG. The patient DB 221a is a DB that stores the prescription content and the clinical test value received at the pharmacy, and stores the prescription content and the clinical test value received by the reception unit 211 in association with the patient ID. The patient DB 221a has a "patient ID" in which information for identifying a patient is stored, a "patient name" in which the name of the patient is stored, a "reception date" in which the date on which the prescription is received, and a prescription which is the content of the received prescription. In addition to the “medicine” in which the accepted drug is stored, the “clinical test value item” in which the type of accepted clinical test value is stored, and the “clinical test value” in which the value of the accepted clinical test value is stored, It is configured to have an “inspection acquisition place”.

Returning to FIG. 10, the display switching reception unit 215 receives the display method of the clinical test value and displays the display of the clinical test value according to the received display method on the display unit 24.
Specifically, the display switching reception means 215 receives the display method of the clinical test value. The display method of the clinical test value is a display method as to whether or not to display the clinical test value according to the acquisition place of the clinical test value. As for the display method of the clinical test value, when the display is made separately, the distinguishing method is selected. For the display method of the laboratory test value, for example, select "no distinction", "distinguish/change display depending on location", "distinguish/display only medical institution", or "distinguish/display only home". Accept.

The display unit 214a groups the clinical test values based on the prescription content and the clinical test value received by the receiving unit 211 and the clinical test value and the relationship extracted by the extracting unit 212, and the respective clinical test values are the drug and the clinical value. Data of a display screen configured to be distinguishable for each relationship with the inspection value is generated and displayed on the display unit 24. The display unit 214a displays the clinical test value according to the display method received by the display switching reception unit 215.

Here, the display screen data displayed on the display unit 24 by the display unit 214a will be described with reference to FIG. FIG. 12 is a diagram showing that the display screen data generated by the display unit 214a is displayed on the display unit 24. Note that points common to the first embodiment will be briefly described.

FIG. 12A shows the display data generated by the display unit 214a when the display switching reception unit 215 receives "no distinction".
In the display area V2a, since "no distinction" is selected, it is displayed as the diagram L1 without distinction of the place where the clinical test value of systolic blood pressure was acquired.
FIG. 12(2) shows display data generated by the display unit 214a when the display switching reception unit 215 receives "discriminate/change display depending on location".
In the display area V2a, "differentiate/change display depending on location" is selected, so the clinical test value of systolic blood pressure whose acquired location is α clinic is displayed as a diagram L2, and the acquired location is home. The laboratory test value of the systolic blood pressure is displayed as a diagram L3.
FIG. 12(3) shows display data generated by the display unit 214a when the display switching reception unit 215 receives "discriminate/display only medical institution".
In the display area V2a, "Distinct/Display only medical institution" is selected, and thus the clinical test value of systolic blood pressure whose acquired location is α clinic is displayed as a diagram L4. Incidentally, the clinical test value of systolic blood pressure where the acquired place is home is excluded from the diagram L4, but only the mark is displayed.

In this way, by displaying the clinical test value by distinguishing the place where the clinical test value was acquired, the efficacy and side effects of the prescribed drug can be appropriately grasped.
For example, the systolic blood pressure may be measured by a medical staff, causing the patient to be nervous and displaying a blood pressure higher than the original blood pressure. Therefore, the pharmacist can grasp the original maximum blood pressure by distinguishing and displaying the place where the maximum blood pressure was acquired.

As described above, in the present embodiment, since the clinical test value can be displayed by distinguishing the place where the clinical test value is acquired, the pharmacist must appropriately understand the efficacy and side effects of the prescribed drug. Therefore, it is possible to efficiently grasp the information necessary for prescription audit for the prescription given to the patient.

It should be noted that the present invention is not limited to the above-described embodiment, and modifications, improvements, etc. within the scope of achieving the object of the present invention are included in the present invention.

Further, the present invention can be applied to the terminal device having the functional configuration shown in FIG. At this time, having the functional configuration shown in FIG. 3 means that in addition to installing software that realizes the functional configuration in a terminal device, the software installed in a predetermined server is used by the terminal device via a network. Including possible states. That is, the present invention can be applied to a so-called ASP service that provides a business application to a customer through the Internet.

Further, in the present embodiment, the clinical test value is displayed based on the group based on the relationship between the clinical test value displayed by selecting the drug and the selected drug, but before accepting the selection, Laboratory values may be displayed based on their relationship to all drugs. Further, by selecting a clinical test value item or a diagram on a graph, a drug having a relationship with the selected clinical test value may be clearly displayed. Here, the display in which the medicine is clear means that, for example, only the medicine having the relationship may be displayed on the display unit, or the display color of the medicine having the relationship is different from that of other medicines. The display may be highlighted.

In addition, in the present embodiment, the clinical test value that is not related to the drug is displayed in the display area V4, but the present invention is not limited to this. The inspection value may not be displayed.

Further, in the present invention, the clinical test value received by the reception means 211 is not limited by which medical institution was acquired. For example, it may be a clinical test value acquired at a pharmacy where the display device 2 is installed, or a clinical test value acquired at a medical institution other than the pharmacy where the display device 2 is installed.
The clinical test value acquired by another medical institution accepted by the accepting unit 211 is not limited to the clinical test value input by the person in charge by the person in charge, and may be accepted from another medical institution via a network line.

The series of processes described above can be executed by hardware or software.
In other words, the functional configuration of FIG. 3 is merely an example and is not particularly limited. That is, it is sufficient for the computer to have a function capable of executing the above-described series of processing as a whole, and what kind of functional block is used to realize this function is not particularly limited to the example of FIG.
Further, one functional block may be configured by hardware alone, software alone, or a combination thereof.

When the series of processes is executed by software, a program forming the software is installed in a computer or the like from a network or a recording medium.
The computer may be a computer embedded in dedicated hardware. Further, the computer may be a computer capable of executing various functions by installing various programs, for example, a general-purpose personal computer.

DESCRIPTION OF SYMBOLS 1 Administrator device 2 Display device 3 which displays a clinical test value 3 Display 21 Control part 22 Storage part 23 Input part 24 Display part 211 Reception means 212 Extraction means 213 Grouping means 214 Display means 221 Patient DB
222 Clinical laboratory value DB
223 Attachment DB

Claims (13)

Based on the drug described in the prescription of the patient and the clinical test value of the patient, the clinical test value having at least one of a plurality of types of relationships including the effect of the drug and the side effect of the drug with respect to the specific drug Extraction means for extracting
Wherein the particular agent, and display means for displaying at least one of a change in pre-Symbol laboratory values extracted by the extracting means and the laboratory values,
A display device for displaying a clinical test value. The display means, with each drug agents described in the prescription, at least one of a change in the extracted laboratory and the laboratory by the extracting means, is extracted by the respective the drug said extracting means The display device for displaying a clinical test value according to claim 1, wherein the relationship with the clinical test value is displayed in a distinguishable display form. A grouping means for grouping the clinical laboratory values based on the type of the relationship with the specific drug,
The display device for displaying clinical test values according to claim 1, wherein the display unit displays the grouped clinical test values in a distinguishable manner for each group. In the grouping, one of the laboratory test values may be classified into different groups for each drug.
A display device for displaying the clinical test value according to claim 3. The grouping is performed for each effect of the drug and side effects of the drug,
A display device for displaying the clinical test value according to claim 3. The grouping may be classified into a group of drug side effects when the value of the laboratory test value is a predetermined value,
A display device for displaying the clinical test value according to claim 5. The display means, in response to accepting the selection of the specific drug, the clinical test value having the relationship with the specific drug, and the clinical test having no relationship with the specific drug. Display values and,
A display device for displaying the clinical test value according to any one of claims 1 to 6. The display unit displays the laboratory test value by distinguishing it at the place where the laboratory test value was acquired,
A display device for displaying the clinical test value according to any one of claims 1 to 7. Based on the drug described in the patient's prescription and the clinical test value of the patient, at least one of a plurality of types of relationships including the effect of the drug and the side effect of the drug with respect to the specific drug transmitted from the terminal device. Extracting means for extracting the clinical laboratory value having
For the particular agent, and display information transmission means for transmitting information for displaying at least one of a change in pre-SL laboratory and the laboratory values extracted by the extracting unit to the terminal device,
A server that includes. A method for displaying clinical laboratory values performed by a display device, comprising:
Based on the drug described in the prescription of the patient and the clinical test value of the patient, the clinical test value having at least one of a plurality of types of relationships including the effect of the drug and the side effect of the drug with respect to the specific drug An extraction step to extract
Wherein the particular agent, and a display step of displaying at least one of a change in pre-Symbol laboratory values extracted in the extraction step and the laboratory values,
Display method of clinical laboratory value including. A method for displaying clinical laboratory values performed by a server,
Based on the drug described in the patient's prescription and the clinical test value of the patient, at least one of a plurality of types of relationships including the effect of the drug and the side effect of the drug with respect to the specific drug transmitted from the terminal device. An extraction step of extracting the clinical laboratory value having
Wherein the particular agent, and display information transmission step of transmitting the information for displaying at least one of changes in those pre-SL laboratory and the laboratory values extracted by the extracting unit to the terminal device,
Display method of clinical laboratory value including. On the computer,
Based on the drug described in the prescription of the patient and the clinical test value of the patient, the clinical test value having at least one of a plurality of types of relationships including the effect of the drug and the side effect of the drug with respect to the specific drug An extraction function to extract
Wherein the particular agent, and a display function for displaying at least one of a change in pre-Symbol extraction laboratory and the laboratory values extracted by the feature,
A program that realizes. On the computer,
Based on the drug described in the patient's prescription and the clinical test value of the patient, at least one of a plurality of types of relationships including the effect of the drug and the side effect of the drug with respect to the specific drug transmitted from the terminal device. An extraction function for extracting the clinical laboratory value having
Wherein the particular agent, and a display information transmitting function of transmitting the information for displaying at least one of a change in the extracted laboratory and the laboratory to the terminal device by the previous SL extraction function,
A program that realizes.

Images